IONIS PARTNER GSK ANNOUNCES HIBSAGO (BEPIROVIRSEN) APPROVED IN THE U.S. FOR THE TREATMENT OF CHRONIC HEPATITIS B (CHB)

Reuters · 2d ago

Please log in to view news